Showing 1071-1080 of 1964 results for "".
- Bioactive Chitosan–dECM Composite Shows Preclinical Promise for Inflammatory Hair Losshttps://modernaesthetics.com/news/bioactive-chitosandecm-composite-shows-preclinical-promise-for-inflammatory-hair-loss/2485093/A novel topical composite combining amine-activated carboxymethyl chitosan (aaCMC) and hydrolyzed decellularized extracellular matrix (h-dECM) demonstrated antioxidant, immunomodulatory, and regenerative effects in preclinical models of inflammatory scalp injury, according to new research publish
- Sculpture OK'd as Double Chin Treatmenthttps://modernaesthetics.com/news/sculpsure-oked-as-double-chin-treatment/2472190/Cynosure's SculpSure® is now cleared for submental fat reduction. The U.S. Food and Drug Administration (FDA) granted an expanded FDA 510(k) clearance for this area, Hologic, Inc. reports.
- BOTOX Cosmetic, IFundWomen Launch Crowdfunding Campaignshttps://modernaesthetics.com/news/botox-cosmetic-and-ifundwomen-launch-crowdfunding-campaigns/2473493/Allergan Aesthetics announced the next chapter of the BOTOX Cosmetic and IFundWomen grant program with the launch of crowdfunding campaigns for the women entrepreneurs. The brand
- Federal Court Rules In Favor Of Permanent Injunction In InMode Counterfeit Device Casehttps://modernaesthetics.com/news/federal-court-grants-permanent-injection-to-inmode-in-counterfeit-device-case/2475361/The U.S. District Court for the Central District of California has ruled in favor of InMode Ltd., granting a default judgment against multiple DHGate sellers accused of promoting and distributing counterfeit aesthetic medical devices, the company announced in a press release. In its May 6
- Letybo (letibotulinumtoxinA-wlbg) Receives FDA Approvalhttps://modernaesthetics.com/news/fda-grants-approval-for-letybo-letibotulinumtoxina-wlbg/2473551/Hugel America, Inc., announced the achievement of a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval for its neurotoxin, Letybo. "We are thrilled with the FDA's approval of Letybo. This is a huge achievement for Hugel as we
- Winners of the BTL Cares Scholarship Program Announcedhttps://modernaesthetics.com/news/winners-of-the-btl-cares-scholarship-program-announced/2473376/BTL Industries, along with professional golfer Michelle Wie West, have announced the winners of the second annual BTL Cares Scholar Draft. The program awards five student-athletes a $15,000 grant for tuition and college fees. The Scholar Draft aims to empow
- BTL, Andre Drummond Announce Winners of the BTL Cares Scholarship Programhttps://modernaesthetics.com/news/btl-andre-drummond-announce-winners-of-the-btl-cares-scholarship-program/2473201/BTL and professional basketball player Andre Drummond have selected the five winners of their first-ever scholarship program – the BTL Scholar Draft. The program awarded each of the five students a $15,000 grant towards tuition and college fees. The Scholar Dra
- BTL Gives Back: Company Announces Scholarship Program with Professional Basketball Player Andre Drummondhttps://modernaesthetics.com/news/btl-gives-back-company-announces-scholarship-program-with-professional-basketball-player-andre-drummond/2473165/The BTL SCHOLAR DRAFT will grant five student athletes $15,000 each toward their college tuition. In addition, BTL has partnered with renowned, professional basketball player Andre Drummond to promote the BTL SCHOLAR DRAFT and award the winners. The program officially ki
- FDA Clears Wontech’s Sandro Dual Laserhttps://modernaesthetics.com/news/fda-clears-wontechs-sandro-dual-laser/2472905/The U.S. Food and Drug Administration granted 510 (K) marketing clearance to Wontech’s Sandro Dual, a hybrid Nd:YAG & Alexandrite laser device. In the hybrid mode, by irradiating a short time difference between two wavelengths of 755nm and 1064nm, the laser accurately hits its
- Sculpture OK'd for Back, Inner and Outer Thighshttps://modernaesthetics.com/news/sculpsure-oked-for-back-inner-and-outer-thighs/2472220/The U.S. Food and Drug Administration (FDA) granted an expanded clearance for Cynosure's SculpSure to treat the back and inner and outer thighs. The SculpSure treatment is already FDA-cleared for treatment of the abdom